Radiometer Medical ApS

What Radiometer Medical ApS does

Radiometer Medical ApS, headquartered in Brønshøj, Denmark, is a medical device manufacturer specializing in acute care diagnostics, founded in 1954 and operating today as a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR). The company designs, produces, and sells blood gas analyzers (ABL9, ABL800 FLEX, ABL90 FLEX, ABL90 FLEX PLUS), the AQT90 FLEX immunoassay analyzer, transcutaneous monitors (TCM5 FLEX, PeriFlux 6000), and a recurring consumables portfolio including *safe*PICO syringes, *safe*CLINITUBES capillary tubes, QC ampoules, and tc*p*O2 sensors. Its technology stack combines proprietary sensor and cartridge-based measurement chemistry with workflow software (1st Automatic for bedside patient-sample linkage, AQURE for centralized POC IT, AQM for automated quality assurance) and is delivered as a closed-system platform tied to its consumables. Underlying technical differentiators include 35-second time-to-result from 65 µL samples, multi-parameter test menus (up to 19 parameters including creatinine and urea), >23 hours/day analyzer uptime, built-in cybersecurity on Microsoft-supported operating systems, and integrations with HIS/LIS/EMR, patient monitoring systems, ventilators, and polysomnography systems.

The company generates revenue through a hardware-plus-consumables razor-and-blade model. Analyzer and monitor sales provide the upfront capital stream, while proprietary consumables (blood collection syringes, capillary tubes, QC ampoules, tc*p*O2 sensors, immunoassay reagents) generate ongoing pull-through revenue from the installed base. Service and support — including accreditation assistance, training, remote support, and Data Insights services — contribute a third layer. Radiometer goes to market primarily through direct enterprise field sales targeting hospitals, ICUs, emergency departments, NICUs, wound care clinics, and sleep labs, supplemented by a distributor network in regions without direct coverage; it operates local country websites in 40+ markets and sells into 109 countries. Customer segments span acute hospital care (primary), wound care and vascular disease, and sleep diagnostics, with HemoCue retained as a sub-brand for hematology and diabetes point-of-care testing. In 2026 the company announced a strategic partnership with Etiometry Inc to layer AI-based clinical decision support onto its diagnostic data.

Name

Radiometer Medical ApS

Legal name

Radiometer Medical ApS

Website

https://radiometer.com

Company type

Private

Founded year

1954

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Radiometer Medical ApS, a Danaher subsidiary, manufactures blood gas analyzers, transcutaneous monitors, immunoassay analyzers, and proprietary consumables for acute care diagnostics in hospitals across 109 countries.

Ownership category

akta.pro rank

Product category

Acute Care Diagnostic Instruments (Blood Gas and Immunoassay Analyzers)

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)

akta.pro secondary industries

Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Blood gas analyzers
• Acute care diagnostics
• Point-of-care testing
• Transcutaneous monitoring
• Immunoassay analyzers

Headquarters

HQ city

Brønshøj

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Blood gas analyzers: Sale of bench-top and point-of-care blood gas analyzers including ABL90 FLEX, ABL90 FLEX PLUS, and ABL800 FLEX for acute care testing in hospitals and clinical settings.
2. Transcutaneous monitors: Sale of TCM5 FLEX and PeriFlux 6000 transcutaneous monitoring devices for neonatal, pediatric and adult patient monitoring.
3. Immunoassay analyzers and tests: Sale of AQT90 FLEX benchtop immunoassay analyzer and associated test cartridges for biomarkers including PCT, CRP, Troponin, and NT-proBNP.
4. Consumables and samplers: Ongoing revenue from consumables including *safe*PICO syringes, *safe*CLINITUBES capillary tubes, QC ampoules, and tc*p*O2 sensors.
5. Service and support: Customer care services including accreditation support, training, and technical support for installed analyzer base.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Radiometer Medical ApS develops, manufactures, and sells acute care diagnostic instruments and consumables. Its core offerings are blood gas analyzers (ABL9, ABL800 FLEX, ABL90 FLEX, ABL90 FLEX PLUS) that measure up to 19 parameters from a 65 µL sample in 35 seconds, the AQT90 FLEX immunoassay analyzer for biomarkers (PCT, CRP, Troponin, D-dimer, NT-proBNP, βhCG), TCM5 FLEX and PeriFlux 6000 transcutaneous monitors for non-invasive oxygenation/ventilation monitoring, AQURE centralized point-of-care IT, 1st Automatic sample identification, and *safe*PICO syringes and *safe*CLINITUBES capillaries. Products are sold to hospitals, ICUs, emergency departments, neonatal intensive care units, and other acute care settings in 109 countries.

Product overview

Radiometer Medical ApS offers a comprehensive acute care diagnostics portfolio consisting of blood gas analyzers (ABL9, ABL800 FLEX, ABL90 FLEX, ABL90 FLEX PLUS), the AQT90 FLEX immunoassay analyzer for biomarker testing (PCT, CRP, D-dimer, NT-proBNP, Troponin, βhCG), transcutaneous monitors (TCM5 FLEX, PeriFlux 6000), and supporting consumables including *safe*PICO syringes, *safe*CLINITUBES capillary tubes, and QC ampoules. The portfolio is unified through the AQURE POC IT platform for centralized device management, with workflow automation via 1st Automatic and quality management through AQM. The company operates as part of the Danaher group, with HemoCue as an affiliated brand for hematology and diabetes point-of-care testing.

Differentiator

Problem solved

Functional benefit

Brands

• HemoCue: Part of the Radiometer Group, HemoCue develops, produces and markets medical diagnostic products for Point of Care testing, including hematology and diabetes products.

Products and services

• ABL800 FLEX blood gas analyzer A reference-point benchtop blood gas analyzer that delivers results on up to 18 critical parameters from a single sample with FLEXQ Drop-n-Go hands-free analysis for up to three successive samples and built-in cybersecurity, intended for hospital clinical chemistry and acute care laboratories.
• ABL90 FLEX blood gas analyzer Fast point-of-care blood gas analyzer delivering 17 vital parameters in 35 seconds from a 65 µL blood sample, featuring Automatic Quality Management (AQM) and built-in cybersecurity, intended for ICU, ED, and NICU.
• ABL90 FLEX PLUS blood gas analyzer Point-of-care blood gas analyzer delivering up to 19 parameters including creatinine and urea in 35 seconds from a 65 µL sample with uptime >23 hours per day, designed for ED, ICU, and NICU point-of-care testing including kidney function assessment.
• ABL9 blood gas analyzer Compact blood gas analyzer for acute care testing with critical parameter measurement capabilities, referenced on the POC creatinine analyzer category page.
• AQT90 FLEX immunoassay analyzer Benchtop immunoassay analyzer that brings rapid biomarker assessment to the bedside, delivering PCT results in less than 21 minutes and supporting CRP, D-dimer, NT-proBNP, Troponin I, and βhCG, intended for acute care biomarker testing including sepsis detection.
• TCM5 FLEX transcutaneous monitor Compact transcutaneous monitor providing continuous non-invasive measurement of oxygenation (tcPO2) and ventilation (tcPCO2) for neonatal, pediatric and adult ICU patients, with connections to ventilators, patient monitoring systems, polysomnography systems, and data management systems.
• PeriFlux 6000 tcPO2 stand-alone transcutaneous monitor Stand-alone transcutaneous monitor for assessing tissue oxygen with up to 8 sensors of tcPO2 measurement, reproducible TCOM test protocols, and HIPAA-compliant data handling including password-protected access, encrypted hard drive, and audit trail; used for wound healing capacity and vascular disease assessment.
• AQURE POC IT solution Centralized point-of-care IT solution providing a complete overview and access to manage the performance of connected POC analyzers, intended for hospital POC coordinators and laboratory managers running multi-device fleets.
• 1st Automatic sample identification solution Bedside workflow solution that registers patient, operator, and sampler IDs and automatically links and transmits them to the hospital information system (HIS/LIS/EMR) to minimize patient sample mix-up risk in blood gas testing workflows.
• *safe*PICO Aspirator syringe Pre-barcoded aspirating syringe with dry electrolyte-balanced heparin and a magnetic mixing ball, designed for arterial blood gas sampling with enhanced operator safety features.
• *safe*PICO and PICO70 self-fill syringes Self-fill arterial blood gas syringes that fill without vacuum to reduce hemolysis risk and feature pre-barcoded identifiers for sample tracking.
• *safe*CLINITUBES capillary tubes Plastic capillary tubes with rounded ends designed for capillary blood gas sampling, featuring fast filling capabilities to minimize preanalytical error.
• QC ampoules for blood gas analyzers Quality control ampoules used with Radiometer blood gas analyzers to support regulatory compliance and routine quality assurance of testing.
• HemoCue point-of-care diagnostics Part of the Radiometer Group, HemoCue develops, produces, and markets medical diagnostic products for point-of-care testing including hematology (hemoglobin, white blood cell differential) and diabetes (glucose) measurements.

Quantifiable outcome

• 35 seconds to result for ABL90 FLEX analyzers
• +4 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability3 records

Feature11 records

Partnerships

One partnership is on record.

• Etiometry InccoreTechnology or Integration · 17 June 2026Radiometer Medical ApS partnered with Etiometry Inc to integrate acute care diagnostics with AI-based clinical decision-support software. This strategic partnership enables combination of Radiometer's blood gas and critical care testing capabilities with Etiometry's AI-powered clinical decision support technology, supporting enhanced patient monitoring and clinical decision-making in acute care settings.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Nova Biomedical: Nova Biomedical is a direct peer in blood gas and electrolyte analyzers (Stat Profile and pHOx lines), competing for hospital and clinical laboratory customers with a focus on critical care diagnostics comparable to Radiometer's ABL series.
• Siemens Healthineers: Siemens Healthineers competes directly with the RAPIDPoint and RAPIDLab blood gas analyzers, serving the same hospital acute care customers with a broader diagnostics portfolio. It is one of the largest incumbents in the blood gas/electrolyte analyzer market.
• EKF Diagnostics: EKF Diagnostics is a direct peer in POC blood gas, hemoglobin, and electrolyte testing, with products like the Quik-Read and DiaSpect brands. It competes with Radiometer's ABL analyzers and HemoCue subsidiary in point-of-care settings.
• Roche Diagnostics: Roche competes directly via the cobas b 123 and b 221 blood gas analyzers, with a global distribution and clinical chemistry footprint that often makes it a single-vendor choice for hospital systems evaluating POC diagnostics alongside Radiometer.
• OPTI Medical (IDEXX): OPTI Medical manufactures blood gas and electrolyte analyzers (OPTI CCA-TS2) and is a direct peer in the acute care blood gas market, serving hospitals and clinical laboratories with optical fluorescence-based measurement technology.
• Werfen: Werfen is a direct peer through its GEM Premier blood gas analyzer line, which competes head-to-head with Radiometer's ABL series in hospital POC. Both target ICU, ED, and OR customers with cartridge-based, low-maintenance blood gas systems.
• Abbott: Abbott's i-STAT System is a direct competitor in handheld blood gas and immunoassay POC testing, with a particularly strong presence in ED and critical care. Its broad diagnostics portfolio and global reach put it in direct contention with Radiometer for hospital POC contracts.

Emerging players

• Mindray Bio-Medical: Mindray is an emerging player in blood gas and POC diagnostics with a growing global footprint, particularly in emerging markets. Its BC-7500 series and POC analyzers compete with Radiometer in cost-sensitive hospital segments and expansion geographies.
• Masimo: Masimo is an emerging competitor in non-invasive patient monitoring, with pulse oximetry, capnography, and continuous hemoglobin technologies that overlap with Radiometer's TCM5 FLEX and pulse oximetry-adjacent monitoring. Its shift toward parameter expansion could pressure Radiometer's transcutaneous monitor business over time.
• ICU Medical: ICU Medical offers blood gas syringes and consumables (formerly Smiths Medical) that overlap with Radiometer's *safe*PICO syringe and *safe*CLINITUBES capillary lines. While not a direct analyzer competitor, it competes in the same hospital acute care customer base for pre-analytical supplies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/radiometermedical
• Facebookfacebook.com/radiometermedical
• LinkedInlinkedin.com/company/radiometer-medical
• Xx.com/RadiometerMed

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Radiometer Medical ApS